Table 1 VEGF and BPTF expression in tumor tissues from 75 patients with lung adenocarcinoma and the correlation between their expression and the clinicopathological features
Clinicopathological features | Case number | VEGF | BPTF | |||||
|---|---|---|---|---|---|---|---|---|
 +  | − | P value |  +  | − | P value | |||
Age (years) |  < 60 | 31 | 20 | 11 | 0.901 | 15 | 16 | 0.599 |
 ≥ 60 | 44 | 29 | 15 | 24 | 20 | |||
Sex | Male | 45 | 30 | 15 | 0.766 | 26 | 19 | 0.22 |
Female | 30 | 19 | 11 | 13 | 17 | |||
Lymphatic metastasis | Yes | 35 | 28 | 7 | 0.013 | 25 | 10 | 0.002 |
No | 40 | 21 | 19 | 14 | 26 | |||
Clinical stages | I | 17 | 11 | 6 | 0.033 | 5 | 12 | 0.01 |
II | 22 | 10 | 12 | 10 | 12 | |||
III | 19 | 17 | 2 | 10 | 9 | |||
IV | 17 | 11 | 6 | 14 | 3 | |||
T | T1 + T2 | 37 | 22 | 15 | 0.292 | 22 | 15 | 0.202 |
T3 + T4 | 38 | 27 | 11 | 17 | 21 | |||